{"id":57488,"date":"2024-02-27T17:46:46","date_gmt":"2024-02-27T17:46:46","guid":{"rendered":"https:\/\/medsname.com\/stanhep-25-heparin-sodium-injection\/"},"modified":"2026-05-01T10:49:14","modified_gmt":"2026-05-01T10:49:14","slug":"stanhep-25-heparin-sodium-injection","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/stanhep-25-heparin-sodium-injection\/","title":{"rendered":"Stanhep 25 Heparin Sodium Injection"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Stanhep 25?<\/h3>\n<p style=\"margin:0;\"><strong>Stanhep 25<\/strong> este un flacon de 5 mL cu heparin\u0103 sodiu nefrac\u021bionat\u0103 de 25.000 UI, produs de un fabricant certificat WHO-GMP \u2014 un anticoagulant parenteral indirect administrat prin perfuzie intravenoas\u0103 sau injec\u021bie subcutanat\u0103 \u00een spital. Heparina ac\u021bioneaz\u0103 prin poten\u021bierea antitrombinei, care apoi inactiveaz\u0103 trombina (IIa) \u0219i factorul Xa. Efectul este imediat (IV) \u0219i timpul de \u00eenjum\u0103t\u0103\u021bire este scurt (60-90 min) \u2014 ceea ce o face anticoagulantul de alegere atunci c\u00e2nd sunt importante debutul rapid, \u00eencetarea rapid\u0103 \u0219i reversarea cu protamin\u0103 (sindrom coronarian acut, punte perioperatorie, dializ\u0103, insuficien\u021b\u0103 renal\u0103 unde LMWH se acumuleaz\u0103). Dozarea se face \u00een func\u021bie de greutate \u0219i se ajusteaz\u0103 pentru aPTT de 1,5-2,5x valoarea ini\u021bial\u0103 sau anti-Xa 0,3-0,7 UI\/mL. Principala complica\u021bie care pune via\u021ba \u00een pericol este trombocitopenia indus\u0103 de heparin\u0103 (HIT), o reac\u021bie imun\u0103 care apare de obicei \u00een zilele 5-10. Reversare: sulfat de protamin\u0103. Acesta este un produs utilizat exclusiv \u00een spital, administrat sub supraveghere medical\u0103 \u2014 nu pentru auto-injec\u021bie.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 22px 0;border-radius:4px;font-size:14px;\"><strong>Anticoagulant pentru uz intravenos\/subcutanat exclusiv \u00een spital.<\/strong> Stanhep 25 (heparin\u0103 sodic\u0103 25.000 UI pe flacon de 5 mL) este administrat\u0103 de c\u0103tre clinician instrui\u021bi sub monitorizare aPTT sau anti-Xa. Nu este destinat\u0103 auto-inject\u0103rii \u00een regim ambulator. Pentru profilaxia sau tratamentul TAV la domiciliu, majoritatea pacien\u021bilor primesc acum heparin\u0103 cu greutate molecular\u0103 mic\u0103 (enoxaparin\u0103, dalteparin\u0103) sau un DOAC.<\/div>\n<h2 class=\"wp-block-heading\">Ce este Stanhep 25?<\/h2>\n<p>Stanhep 25 este heparin\u0103 nefrac\u021bionat\u0103 (UFH) sodic\u0103 25.000 UI pe flacon de 5 mL, provenind de la un produc\u0103tor certificat WHO-GMP, furnizat\u0103 \u00een seturi de 1-10 flacoane. UFH este prototipul anticoagulantului parenteral \u00een uz clinic din anii 1930. \u00cen ciuda ascensiunii LMWH \u0219i DOAC, p\u0103streaz\u0103 roluri cheie acolo unde conteaz\u0103 debutul rapid, \u00eencetarea rapid\u0103 \u0219i reversibilitatea cu protamin\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Cum ac\u021bioneaz\u0103 heparina<\/h2>\n<p>Heparina se leag\u0103 de antitrombina III prin secven\u021ba sa pentazaharidic\u0103 \u0219i accelereaz\u0103 inhibarea de c\u0103tre antitrombin\u0103 a trombinei (factorul IIa) \u0219i a factorului Xa de aproximativ 1.000 de ori. UFH inhib\u0103 IIa \u0219i Xa aproximativ \u00een mod egal; LMWH inhib\u0103 preferen\u021bial Xa. Debutul este imediat la administrare IV; subcutanat debutul apare \u00een 20-30 minute. Timpul de \u00eenjum\u0103t\u0103\u021bire plasmatic este de 60-90 minute, dependent de doz\u0103, permi\u021b\u00e2nd \u00eencetarea rapid\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri aprobate<\/h2>\n<ul>\n<li><strong>Sindrom coronarian acut (NSTEMI \/ angin\u0103 instabil\u0103, STEMI)<\/strong> \u2014 cu antiagregante plachetare \u0219i PCI<\/li>\n<li><strong>Tromboembolism venos acut (TVP, EP)<\/strong> \u2014 \u00een special c\u00e2nd LMWH este nepotrivit\u0103 (insuficien\u021b\u0103 renal\u0103 sever\u0103, interven\u021bii chirurgicale anticipate)<\/li>\n<li><strong>Punte perioperatorie<\/strong> la pacien\u021bii sub tratament anticoagulant pe termen lung care urmeaz\u0103 s\u0103 fie opera\u021bi<\/li>\n<li><strong>Circula\u021bie de bypass cardiopulmonar \u0219i ECMO<\/strong><\/li>\n<li><strong>Terapie renal\u0103 de \u00eenlocuire continu\u0103 (CRRT) \u0219i hemodializ\u0103<\/strong> \u2014 anticoagularea circuitului<\/li>\n<li><strong>Permeabilitatea cateterelor \u0219i liniilor<\/strong> \u2014 doz\u0103 mic\u0103 de flush (preparate separate, cu concentra\u021bie mai mic\u0103)<\/li>\n<li><strong>Punte pentru cardioversie \u00een fibrila\u021bie atrial\u0103<\/strong><\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Doza \u0219i Monitorizare<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:0 0 22px 0;font-size:14px;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;text-align:left;\">Indica\u021bie<\/th>\n<th style=\"padding:8px;text-align:left;\">Doz\u0103 de \u00eenc\u0103rcare<\/th>\n<th style=\"padding:8px;text-align:left;\">Doz\u0103 de \u00eentre\u021binere<\/th>\n<th style=\"padding:8px;text-align:left;\">\u021aint\u0103<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:8px;\">TEV acut (tratament)<\/td>\n<td style=\"padding:8px;\">80 UI\/kg bolus IV<\/td>\n<td style=\"padding:8px;\">18 UI\/kg\/h perfuzie IV<\/td>\n<td style=\"padding:8px;\">aPTT 1,5\u20132,5\u00d7 valoarea ini\u021bial\u0103<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;\">SCA<\/td>\n<td style=\"padding:8px;\">60 UI\/kg (max 4.000 UI)<\/td>\n<td style=\"padding:8px;\">12 UI\/kg\/h (max 1.000 UI\/h)<\/td>\n<td style=\"padding:8px;\">aPTT 50\u201370 sec<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;\">Profilaxie SC<\/td>\n<td style=\"padding:8px;\">\u2014<\/td>\n<td style=\"padding:8px;\">5.000 UI SC la fiecare 8\u201312h<\/td>\n<td style=\"padding:8px;\">F\u0103r\u0103 monitorizare de rutin\u0103<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;\">Bypass cardiopulmonar<\/td>\n<td style=\"padding:8px;\">300\u2013400 UI\/kg IV<\/td>\n<td style=\"padding:8px;\">Readministrare pentru men\u021binerea ACT<\/td>\n<td style=\"padding:8px;\">ACT &gt;480 sec<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Monitoriza\u021bi aPTT sau anti-Xa (0,3\u20130,7 UI\/mL) la fiecare 6 ore dup\u0103 ini\u021biere sau modificare de doz\u0103, apoi zilnic odat\u0103 stabilizat. Verifica\u021bi la baz\u0103 FBC, PT, aPTT, fibrinogen, func\u021bia renal\u0103 \u0219i hepatic\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Trombocitopenie indus\u0103 de heparin\u0103 (HIT)<\/h2>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 22px 0;border-radius:4px;font-size:14px;\"><strong>Suspecta\u021bi HIT<\/strong> dac\u0103 num\u0103rul de trombocite scade cu &gt;50% fa\u021b\u0103 de valoarea ini\u021bial\u0103 (sau sub 100\u00d710<sup>9<\/sup>\/L) de obicei \u00een ziua 5-10 de heparin\u0103 (sau mai devreme la expunere anterioar\u0103 la heparin\u0103). HIT este o reac\u021bie imun\u0103 paradoxal\u0103 protrombotic\u0103 (anticorpi anti-PF4\/heparin\u0103) \u0219i prezint\u0103 un risc de tromboz\u0103 de 30-50%. Ac\u021biune: \u00ceNTRERUPE\u021aI toat\u0103 heparina, inclusiv solu\u021biile de irigare, EVITA\u021aI warfarina p\u00e2n\u0103 la recuperarea trombocitelor \u0219i \u00eencepe\u021bi un anticoagulant non-heparinic (argatroban, danaparoid, fondaparinux sau bivalirudin). Confirma\u021bi cu test ELISA anti-PF4 \u0219i testul de eliberare de serotonin\u0103. Scorul 4Ts ghideaz\u0103 probabilitatea clinic\u0103.<\/div>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<ul>\n<li>S\u00e2ngerare (rata de s\u00e2ngerare major\u0103 ~5% la heparin\u0103 IV terapeutic\u0103)<\/li>\n<li>Trombocitopenie indus\u0103 de heparin\u0103 (HIT) \u2014 tip II, mediat\u0103 imun, cu risc vital<\/li>\n<li>Sc\u0103dere u\u0219oar\u0103 \u0219i benign\u0103 a trombocitelor (HIT tip I, non-imun, tranzitorie)<\/li>\n<li>Hiperkaliemie (suprimare de aldosteron, mai ales \u00een diabet \u0219i insuficien\u021b\u0103 renal\u0103)<\/li>\n<li>Osteoporoza la utilizare prelungit\u0103 &gt;3 luni<\/li>\n<li>Ecchimoz\u0103\/hematom la locul de injectare (administrare subcutanat\u0103)<\/li>\n<li>Reac\u021bii de hipersensibilitate, rareori anafilaxie<\/li>\n<li>Cre\u0219terea enzimelor hepatice (LFT)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii<\/h2>\n<ul>\n<li>Hemoragie major\u0103 activ\u0103<\/li>\n<li>HIT cunoscut sau istoric de HIT (utiliza\u021bi un anticoagulant non-heparinic)<\/li>\n<li>Trombocitopenie sever\u0103 (trombocite &lt;50\u00d710<sup>9<\/sup>\/L)<\/li>\n<li>Hipertensiune sever\u0103 necontrolat\u0103<\/li>\n<li>Interven\u021bii chirurgicale recente intracraniene, oftalmice sau majore cu risc de s\u00e2ngerare<\/li>\n<li>Ulcere peptice cu s\u00e2ngerare activ\u0103, varice esofagiene<\/li>\n<li>Hipersensibilitate la heparin\u0103 sau produse din porc<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Al\u021bi anticoagulan\u021bi\/antiagregante plachetare<\/strong> (warfarin, DOAC, aspirin\u0103, clopidogrel, AINS, fibrinolitice) \u2014 risc adi\u021bional de s\u00e2ngerare; combina\u021bi doar c\u00e2nd este indicat clinic sub supraveghere specializat\u0103.<\/li>\n<li><strong>Perfuzie IV de gliceril trinitrat<\/strong> \u2014 poate reduce efectul heparinei; monitorizarea aPTT ca de obicei.<\/li>\n<li><strong>SSRI\/SNRI<\/strong> \u2014 risc moderat adi\u021bional de s\u00e2ngerare.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Antidot: Sulfat de Protamin\u0103<\/h2>\n<p>Pentru s\u00e2nger\u0103ri majore sau neutralizare pre-urgen\u021b\u0103, sulfatul de protamin\u0103 neutralizeaz\u0103 heparina: 1 mg protamin\u0103 la fiecare 100 UI heparin\u0103 administrat\u0103 \u00een ultimele 2-3 ore, administrare IV lent\u0103 (maxim 50 mg \u00een 10 minute) pentru a evita hipotensiunea \u0219i reac\u021biile anafilactoide. Doza maxim\u0103 unic\u0103 50 mg; reverifica\u021bi aPTT dup\u0103 5-15 minute. Riscul crescut de reac\u021bie la protamin\u0103 la pacien\u021bii cu expunere anterioar\u0103 la insulin\u0103 NPH, alergie la pe\u0219te sau vasectomie.<\/p>\n<h2 class=\"wp-block-heading\">Sarcina \u0219i al\u0103ptarea<\/h2>\n<p>Heparina \u0219i LMWH nu trec prin placent\u0103 \u0219i sunt anticoagulantele de elec\u021bie \u00een sarcin\u0103. LMWH este preferat pentru utilizarea ambulatorie. Al\u0103ptare: heparina nu este excretat\u0103 \u00een laptele matern (molecul\u0103 mare) \u2014 sigur.<\/p>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi Stanhep 25 sub 25\u00b0C, nu congela\u021bi. Dup\u0103 deschiderea unui flacon, respecta\u021bi protocoalele de sterilizare institu\u021bionale. Depozita\u021bi \u00een afara accesului copiilor.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Pot folosi Stanhep 25 acas\u0103?<\/h3>\n<p>Nu. Stanhep 25 este un flacon multidoz\u0103 de \u00eenalt\u0103 concentra\u021bie (25.000 UI\/5 mL) destinat perfuziei IV \u00een spital sau doz\u0103rii SC pentru pacien\u021bii interna\u021bi sub monitorizare aPTT sau anti-Xa. Anticoagularea la domiciliu se face de obicei cu LMWH (enoxaparin\u0103, dalteparin\u0103) sau un DOAC.<\/p>\n<h3 class=\"wp-block-heading\">Care este diferen\u021ba dintre heparin\u0103 \u0219i LMWH?<\/h3>\n<p>Heparina nefrac\u021bionat\u0103 (UFH) este un amestec eterogen care inhib\u0103 \u00een mod egal IIa \u0219i Xa, cu o semivid\u0103 scurt\u0103 \u0219i monitorizare aPTT. LMWH (enoxaparin\u0103, dalteparin\u0103) sunt molecule mai mici, inhib\u0103 preferen\u021bial Xa, au o semivid\u0103 mai lung\u0103 \u0219i predictibil\u0103, pot fi administrate subcutanat f\u0103r\u0103 monitorizare la majoritatea pacien\u021bilor \u0219i reprezint\u0103 alegerea de prim\u0103 inten\u021bie \u00een tratamentul ambulator. UFH este preferat\u0103 atunci c\u00e2nd este necesar\u0103 \u00eencetare rapid\u0103, insuficien\u021b\u0103 renal\u0103 sever\u0103 sau reversibilitate cu protamin\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Ce este HIT \u0219i cum se trateaz\u0103?<\/h3>\n<p>Trombocitopenia indus\u0103 de heparin\u0103 este o reac\u021bie imun\u0103 (anticorpi anti-PF4\/heparin\u0103) care apare de obicei \u00een zilele 5-10 de la administrarea heparinei, provoc\u00e2nd o stare paradoxal\u0103 protrombotica. \u00cenceta\u021bi orice form\u0103 de heparin\u0103 (inclusiv solu\u021bii de irigare), evita\u021bi warfarin p\u00e2n\u0103 la recuperarea trombocitelor \u0219i ini\u021bia\u021bi un anticoagulant non-heparinic (argatroban, danaparoid, fondaparinux sau bivalirudin\u0103). Confirma\u021bi cu test ELISA anti-PF4 \u0219i test de eliberare de serotonin\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Cum se neutralizeaz\u0103 efectul heparinei?<\/h3>\n<p>Sulfat de protamin\u0103. 1 mg la fiecare 100 UI heparin\u0103 administrat\u0103 \u00een ultimele 2-3 ore, administrare IV lent\u0103. Doza maxim\u0103 unic\u0103 50 mg. Verifica\u021bi din nou aPTT la 5-15 minute dup\u0103 administrare.<\/p>\n<h3 class=\"wp-block-heading\">De ce se monitorizeaz\u0103 aPTT?<\/h3>\n<p>R\u0103spunsul la doza de UFH este impredictibil datorit\u0103 leg\u0103rii variabile la proteinele plasmatice. aPTT reflect\u0103 anticoagularea pe calea intrinsec\u0103; \u021binta terapeutic\u0103 este de 1,5-2,5\u00d7 valoarea de baz\u0103 (de obicei 50-70 sec) pentru anticoagulare terapeutic\u0103. Anti-Xa (0,3-0,7 UI\/mL) este alternativa disponibil\u0103 acolo unde este posibil.<\/p>\n<h3 class=\"wp-block-heading\">Este heparin\u0103 sigur\u0103 \u00een sarcin\u0103?<\/h3>\n<p>Da \u2014 heparina (\u0219i LMWH) nu trec placenta \u0219i sunt anticoagulantele de alegere atunci c\u00e2nd este necesar\u0103 anticoagularea \u00een sarcin\u0103. Warfarina este teratogen\u0103; DOAC-urile nu au date suficiente \u00een sarcin\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Poate heparin\u0103 s\u0103 provoace hiperkaliemie?<\/h3>\n<p>Da \u2014 \u00een special la pacien\u021bii cu diabet \u0219i insuficien\u021b\u0103 renal\u0103, datorit\u0103 suprimirii aldosteronului. Verifica\u021bi potasiul la ini\u021biere \u0219i \u00een timpul terapiei prelungite.<\/p>\n<h3 class=\"wp-block-heading\">Ce se \u00eent\u00e2mpl\u0103 dac\u0103 un copil \u00eenghite accidental un flacon cu heparin\u0103?<\/h3>\n<p>Heparina nu este absorbit\u0103 pe cale oral\u0103 \u2014 ingestia oral\u0103 este practic inofensiv\u0103 din punct de vedere anticoagulant. Duce\u021bi copilul la UPU pentru evaluare indiferent de circumstan\u021be. Expunerea parenteral\u0103 este o situa\u021bie diferit\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Cum se utilizeaz\u0103 heparina \u00een timpul dializei?<\/h3>\n<p>Perfuzie continu\u0103 sau doze \u00een bolus \u00een circuitul de dializ\u0103 previne coagularea \u00een sistemul extracorporal. Dozele sunt stabilite conform protocolului unit\u0103\u021bii; ACT sau aPTT pot fi monitorizate \u00een timpul procedurii.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Stanhep 25 online?<\/h3>\n<p>Pute\u021bi cump\u0103ra Stanhep 25 (25.000 UI pe flacon de 5 mL, 1-10 flacoane) de la MedsBase cu ambalaj discret \u0219i livrare la nivel mondial. Acesta este un produs parenteral destinat utiliz\u0103rii \u00een spital \u2014 trebuie administrat de c\u0103tre cliniciani instrui\u021bi.<\/p>\n<h2 class=\"wp-block-heading\">Alte Anticoagulante \u0219i Antiagregante Plachetare<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/warf\/\">Warf \u2014 Warfarin\u0103 1\/2\/5 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/waf-5\/\">Waf-5 \u2014 Warfarin 5 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/uniwarfin\/\">Uniwarfin \u2014 Warfarin 5 mg (Unichem)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/xarelto-20\/\">Xarelto 20 \u2014 Rivaroxaban 20 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/eliquis\/\">Eliquis \u2014 Apixaban 2,5\/5 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/plavix\/\">Plavix \u2014 Clopidogrel 75 mg (Sanofi)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/anti-coagulants\/\"><strong>R\u0103sfoi\u021bi toate Anticoagulantele \u0219i Antiagregatele<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Heparina nefrac\u021bionat\u0103 este un anticoagulant parenteral administrat \u00een spital care necesit\u0103 monitorizare de laborator (aPTT sau anti-Xa) \u0219i supraveghere clinic\u0103 pentru HIT. Nu este destinat auto-inject\u0103rii. Utiliza\u021bi numai sub supraveghere medical\u0103 cu monitorizarea num\u0103rului de trombocite \u0219i aPTT conform protocolului institu\u021bional.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>S\u0103n\u0103tate general\u0103<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tenovate-clobetasol-cream\/\">Tenovate Clobetasol Cream<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/roliten\/\">Roliten<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/monolith\/\">Monolith<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/zenflox-eye-drops\/\">Zenflox Pic\u0103turi Oculare<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/iverintas-dt-12\/\">Iverintas DT-12<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Previne formarea cheagurilor de s\u00e2nge<br \/>\n\u2705 Reduce riscul de coagulare<br \/>\n\u2705 Trateaz\u0103 tromboza<br \/>\n\u2705 Minimizeaz\u0103 riscul de embolie<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te fluxul sanguin<\/p>\n<p>Stanhep 25 con\u021bine Heparin\u0103 Sodiu.<\/p>","protected":false},"featured_media":57489,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3635,3141,3342],"product_tag":[4311,4312],"class_list":{"0":"post-57488","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-coagulants","7":"product_cat-category-overview","8":"product_cat-general-health","9":"product_tag-heparin-sodium","10":"product_tag-stanhep","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/57488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=57488"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/57489"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=57488"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=57488"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=57488"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=57488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}